治疗恶心和吐的生:系统性审查和元分析的概述
Zhongyu Li1,2, Jiao Wu3, Jinjie Song3
1Institute of Digestive Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
International journal of food sciences and nutrition
|December 10, 2023
概括
生有效地减少了癌症患者接受化疗,术后和怀孕期间的恶心和吐. 这篇评论强调生是一种安全的植物选择,尽管需要进一步的研究来提高元分析质量.
科学领域:
- 综合医学是一个整体的医学.
- 药理学 药理学是指药理学的学科.
- 基于证据的实践实践.
背景情况:
- 恶心和吐是常见的,在各种医疗环境中都有衰弱的症状.
- 生有很长的历史,传统上用于胃肠道疾病.
- 系统审查和元分析对于合成生有效性的证据至关重要.
研究的目的:
- 评估关于生治疗恶心和吐的现有元分析报告和方法质量.
- 整合关于生对化疗诱导的恶心和吐 (CINV),术后恶心和吐 (PONV) 以及与怀孕相关的恶心有效性的证据.
主要方法:
- 进行了对15个元分析的系统审查.
- 通过使用系统审查和元分析 (PRISMA) 2009年准则的首选报告项目来评估元分析报告质量.
- 方法质量使用多次系统性审查评估 (AMSTAR) -2 检查清单进行评估.
主要成果:
- 十五个元分析符合PRISMA指南,表明了良好的报告标准.
- 然而,这些元分析的整体方法质量非常低至低.
- 证据支持生在控制CINV,减少PONV严重性和缓解与怀孕相关的恶心方面的有效性.
结论:
- 生是一种安全有效的植物干预,用于各种类型的恶心和吐.
- 尽管它是有效的,但仍然有必要加强未来对生的元分析的科学和方法严格性.
- 需要进一步进行高质量的研究,以巩固生在治疗恶心和吐方面的证据基础.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
208
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
208
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
167
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
167
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
298
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
298
Pathophysiology of Vomiting
481
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
481
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
282
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
282
Assessment of the Gastrointestinal System I: Subjective Data
200
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
200


